Professor Lisa Horvath

Lisa is the inaugural Director of Medical Oncology and acting Director of Research at the Chris O'Brien Lifehouse. She has an active clinical practice and is involved with a large number of clinical trials in prostate and colorectal cancers in addition to phase I trial work.
  • Scientific Advisory Committee
  • T1/T2 Working Group


Having completed medical school at the University of Sydney and trained in medical oncology at Royal Prince Alfred Hospital Lisa subsequently worked at the Garvan Institute completing her PhD in translational research in 2004. Lisa was appointed to the senior staff of Royal Prince Alfred Hospital in 2003 andn has been a visiting scientist at the Garvan Institute for Medical Research for 13 years and is the Head of Prostate Cancer Therapeutics at The Kinghorn Cancer Centre. 

To unwind at the end of the day Lisa likes to read a good book 

Research Interests:  

Since returning to clinical practice, Lisa's research has focused on drug resistance in castrate-resistant prostate cancer. This work integrates clinical trial work and correlative biomarker studies using both standard and experimental anti-cancer treatments. While mainly a prostate cancer researcher, she has also applied this paradigm to lung and colorectal cancer research.